PRICE T ROWE ASSOCIATES INC /MD/ - SOPHIA GENETICS SA ownership

SOPHIA GENETICS SA's ticker is and the CUSIP is H82027105. A total of 34 filers reported holding SOPHIA GENETICS SA in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SOPHIA GENETICS SA
ValueSharesWeighting
Q2 2023$4,295
-15.9%
958,500
-6.7%
0.00%0.0%
Q1 2023$5,107
+170.9%
1,027,562
+12.3%
0.00%
Q4 2022$1,885
-99.9%
915,266
-4.2%
0.00%
Q3 2022$2,513,000
-64.2%
955,506
-50.8%
0.00%
-100.0%
Q2 2022$7,027,000
-60.8%
1,941,282
-16.3%
0.00%
-50.0%
Q1 2022$17,932,000
-46.6%
2,319,740
-2.6%
0.00%
-33.3%
Q4 2021$33,590,000
-18.8%
2,382,304
+1.0%
0.00%
-25.0%
Q3 2021$41,343,0002,358,4410.00%
Other shareholders
SOPHIA GENETICS SA shareholders Q4 2021
NameSharesValueWeighting ↓
PFM Health Sciences, LP 2,014,024$15,568,0000.58%
GENERATION INVESTMENT MANAGEMENT LLP 6,789,560$52,483,0000.24%
PURA VIDA INVESTMENTS, LLC 829,930$6,415,0000.21%
BANK PICTET & CIE (ASIA) LTD 64,420$498,0000.14%
BANQUE PICTET & CIE SA 2,096,420$16,205,0000.12%
Moloney Securities Asset Management, LLC 71,450$552,0000.11%
GENERAL ELECTRIC CO 1,111,111$8,588,8880.09%
Bank Pictet & Cie (Europe) AG 227,600$1,759,0000.07%
RTW INVESTMENTS, LP 226,589$1,752,0000.04%
DRIEHAUS CAPITAL MANAGEMENT LLC 287,406$2,222,0000.03%
View complete list of SOPHIA GENETICS SA shareholders